C-reactive protein (CRP) is a biomarker of inflammation. Plasma CRP concentrations increase rapidly and dramatically in response to tissue injury or inflammation. High-sensitivity CRP (hs-CRP) is more precise than standard CRP when measuring baseline concentrations and enables a measure of chronic inflammation. hs-CRP has been endorsed by multiple guidelines as a biomarker of atherosclerotic cardiovascular disease risk. It
has been found to be useful in assessment of risk of developing myocardial infarction in patients presenting with acute coronary syndromes and assessment of risk of developing cardiovascular disease or ischemic events in individuals who do not manifest disease at present.
25 Jul